Hematology, 2004 Internal Medicine, 2001 Medical Oncology, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School Albert Einstein College of Medicine of Yeshiva University Graduated: 1998 Medical School University Of Michigan Hospitals Graduated: 1998
Merck
Vice President Clinical Research
Bristol-Myers Squibb Jan 2015 - Nov 14, 2016
Vice President and Head, New Asset Development Teams
Gsk Oct 2013 - Jan 2015
Medicine Development Leader
Gsk Feb 2007 - Oct 2013
Director Clinical Development
Fda Oct 2004 - Feb 2007
Medical Officer
Education:
University of Michigan Medical School 1998 - 2004
Albert Einstein College of Medicine 1994 - 1998
Doctor of Medicine, Doctorates, Medicine
Skills:
Clinical Trials Clinical Development Oncology Clinical Research Drug Development Pharmaceutical Industry Cancer Regulatory Submissions Fda Hematology Protocol Ind Gcp Biotechnology Life Sciences Oncology Clinical Research Epigenetics Clinical Study Design Regulatory Strategy Development U.s. Food and Drug Administration
Interests:
Exercise Sweepstakes Nascar Home Improvement Reading Gourmet Cooking Sports The Arts Golf Home Decoration Cooking Cruises Outdoors Electronics Crafts Music Movies Collecting Kids Automobiles Travel Boating Investing Traveling
We are excited to share the overall survival results from studies -010 and -003, as these data provide new insights into the long-term efficacy and safety of Opdivo in previously treated advanced renal cell carcinoma, said Vicki Goodman, M.D., Development Lead, Melanoma and Genitourinary Cancers,